Latest News

Figure-12

New Treatment on the Horizon – What is a PCSK9 Inhibitor?

Living well with FHStories and insights from people living with Familial Hypercholesterolemia (FH)New Treatment on the Horizon – What is a PCSK9 Inhibitor?by Cat Davis AhmedThis is a hopeful time in the field of Familial Hypercholesterolemia (FH).  Developments in both treatment and in the effort to diagnose … Read More

FIND FH logo

Today, Jan 29, 2015 is a very important day…

Today is a very important day for over 1.5 million Americans and most of them do not know it.  They are unaware they have a life-threatening genetic condition, familial hypercholesterolemia (FH). If left untreated, people living with FH have a 20 times increased risk of premature heart disease and heart attacks.  … Read More

IMPROVE-IT Study Results: An Incremental Improvement

The results of the IMPROVE-IT trial were finally revealed this November during the American Heart

Association (AHA) Scientific Sessions in Chicago. The trial itself remains highly controversial, and its long-

awaited results may set precedence for new therapies in the future and possibly even changes to the clinical … Read More

Screen Shot 2014-11-20 at 2.33.08 PM

IMPROVE-IT Proves that with LDL, Lower is Most Definitely Better

The IMPROVE-IT verdict is in and it will change the practice of cardiovascular disease prevention. For the first time, a non-statin medication has been shown to reduce cardiovascular events (including stroke and MI) when added to a statin. Achieving an LDL level of 53 vs 70 by the end of the trial’s first year translated … Read More

banner_summit14

2014 FH Global Summit – Bridging the Gaps in Care of Familial Hypercholesterolemia

The Second Annual FH Global Summit took place in New York City October 13-14.  The FH Foundation convened a group of 140 doctors, patients, researchers, and industry representatives all focussed on finding and treating people with familial hypercholesterolemia in order to save lives.  It was a resounding success, … Read More